Gujarat Terce Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 357.68 million compared to INR 338.94 million a year ago. Revenue was INR 360.07 million compared to INR 341.47 million a year ago. Net loss was INR 3 million compared to INR 24.75 million a year ago. Basic loss per share from continuing operations was INR 0.4 compared to INR 3.34 a year ago. Diluted loss per share from continuing operations was INR 0.4 compared to INR 3.34 a year ago.